20 Best Performing Stocks Over the Last 20 Years
Twenty years can turn a good business into a very different investment.
Posts Tagged ‘NASDAQ:CORT’
Strong Commercial Execution and Pipeline Opportunities Propel Corcept Therapeutics (CORT)
BUFFALO Funds, an actively managed mutual fund advised by Kornitzer Capital Management, released its second-quarter 2026 investor letter for “Buffalo Mid Cap Discovery Fund”.
Corcept’s (CORT) Cancer Drug Just Cleared Europe’s Toughest Hurdle
On September 18, Corcept Therapeutics (NASDAQ:CORT) said Europe's drug regulator recommended approval for the cancer therapy that has already earned a spot in US cancer treatment...
Blowing Past the Street: 46 Stocks That Crushed Q2 EPS Projections
More than 250 companies announced their earnings performance in the second quarter of the year on Wednesday, July 29, offering a fresh look at how they performed relative to what...
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2026 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2026 Earnings Call Transcript May 1, 2026 Operator: Thank you for standing by, and welcome to Corcept Therapeutics First Quarter...
Corcept (CORT) Upgraded After Key Regulatory Approval for Lifyorli
Corcept Therapeutics Incorporated (NASDAQ:CORT) ranks among the most profitable biotech stocks to buy now.
10 Most Profitable Biotech Stocks to Buy Now
In this article, we will take a look at the 10 Most Profitable Biotech Stocks to Buy Now.
10 Best Biotech Stocks with Highest Upside Potential
In this article, we will take a look at some of the best biotech stocks that are currently offering attractive upside to investors. On April 16, reports from J.P.
7 Best Stocks to Buy for Short Term
In this article, we will take a look at the best stocks to buy for the short term.
Corcept Therapeutics (CORT) Climbs 19.7% as Lifyorli Gets FDA OK
Corcept Therapeutics Inc. (NASDAQ:CORT) is one of the 10 Stocks Investors Are Buying Now.
10 Stocks Investors Are Buying Now: Chewy, Braze, Sarepta, and More
Ten stocks boasted a double-digit rally on Wednesday, mimicking a broader market optimism, helped by expectations of easing tensions in the Middle East.
H.C. Wainwright Cuts Corcept Therapeutics Incorporated (CORT) Price Target, Keeps Buy Rating
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best under-the-radar stocks to buy according to hedge funds. On February 25, H.C.
12 Best Under-the-Radar Stocks to Buy According to Hedge Funds
On March 6, Reuters reported that US and European stock markets ended a volatile week with losses of over 1% as rising geopolitical tensions pushed oil prices higher.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2025 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2025 Earnings Call Transcript February 24, 2026Corcept Therapeutics Incorporated misses on earnings expectations.
Is Corcept Therapeutics Incorporated (CORT) at an inflection point?
Polen Capital, an investment management company, released its fourth-quarter investor letter for “Polen 5Perspectives Small Growth Strategy”.
FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)
Corcept Therapeutics (NASDAQ:CORT) is one of the 17 biotechnology stocks with more than 50% upside.
17 Biotechnology Stocks with More Than 50% Upside
2025 was a year characterized by both challenges and opportunities for the biotechnology sector.
Corcept Therapeutics (CORT) Climbs 26.6% on Stellar Clinical Trial Result
We recently published 10 Stocks With Effortless Double-, Triple-Digit Gains. Corcept Therapeutics Inc. (NASDAQ:CORT) was one of the top performers last week.
Corcept Therapeutics (CORT) Climbs 13.7% on Strong Clinical Trial Results
We recently published 10 Stocks Delivering Double-Digit Gains Effortlessly; 4 Hit Highs. Corcept Therapeutics Inc. (NASDAQ:CORT) was one of the best performers on Thursday.
Is Corcept Therapeutics Incorporated (CORT) The Most Promising Growth Stock According to Analysts?
Corcept Therapeutics Incorporated (NASDAQ:CORT) is among the most promising growth stocks according to analysts.
13 Most Promising Growth Stocks According to Analysts
In this article, we will take a look at the most promising growth stocks according to analysts.
12 Stocks that Will Bounce Back According to Wall Street Analysts
On January 5, Reuters reported that many analysts believe global investors will actively look for opportunities in undervalued areas of the financial markets in 2026.
Corcept Therapeutics (CORT): Analyst Says Shares Pricing in Growth, New Launch
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the Stocks That Could Mint Millionaires in 2026.
15 Stocks That Could Mint Millionaires in 2026
In this article, we discuss the 15 stocks that could mint millionaires in 2026.
Wall Street Firms Tout Corcept Therapeutics Incorporated (CORT) Prospects on Korlym Medication Prospects
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best biotech stocks to buy according to Wall Street analysts. On November 25, H.C.
15 Best Biotech Stocks to Buy According to Wall Street Analysts
In this article, we will examine the 15 Best Biotech Stocks to Buy According to Wall Street Analysts.
Analysts See 70% Upside Potential in Corcept Therapeutics (CORT) Stock
Corcept Therapeutics Incorporated (NASDAQ:CORT) is among the best stocks you’ll wish you bought sooner.
11 Best Stocks You’ll Wish You Bought Sooner
Our list highlights the best stocks you'll wish you bought sooner. Markets often reward those investors who spot inflection points before they become widely known.
Corcept Therapeutics Incorporated (CORT) Modifies Revenue Guidance while Banking on Cushing Syndrome Treatment for Growth
Corcept Therapeutics Incorporated (NASDAQ:CORT) is a must-buy non-tech stock to invest in.
10 Must-Buy Non-Tech Stocks to Invest In
In this article, we will discuss the 10 Must-Buy Non-Tech Stocks to Invest In.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2025 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q3 2025 Earnings Call Transcript November 4, 2025Corcept Therapeutics Incorporated misses on earnings expectations.
What Does Wall Street Think About Corcept Therapeutics (CORT)?
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best stocks to buy with over 50% upside potential.
10 Stocks to Buy With Over 50% Upside Potential
In this article, we will look at the 10 Stocks to Buy With Over 50% Upside Potential.
9 Most Profitable Biotech Stocks to Buy
In this article, we will look at the 9 Most Profitable Biotech Stocks to Buy.
H.C. Wainwright Remains Bullish on Corcept Therapeutics Incorporated (CORT)
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best healthcare stocks with the highest upside.
9 Best Healthcare Stocks with the Highest Upside
In this article, we will look at the 10 Best Healthcare Stocks with the Highest Upside. On October 9, Dr.
Here’s What Makes Corcept Therapeutics (CORT) an Attractive Investment?
ClearBridge Investments, an investment management company, released its “Clearbridge Global Value Improvers Strategy” second-quarter 2025 investor letter.
Corcept Therapeutics Beats Q2 Estimates, Cuts Guidance and Advances NDA for New Cancer Drug
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the 12 Stocks with Consistent Growth to Invest In.
12 Stocks with Consistent Growth to Invest In
In this article, we will be looking at 12 stocks with consistent growth to invest in. Volatility of the market often decides the nature of stocks preferred by an investor.
11 Best Performing Long Term Stocks According to Analysts
In this article, we will look at the 11 Best Performing Long Term Stocks According to Analysts.
Corcept’s (CORT) Multibagger Momentum Builds on Relacorilant and Expanding Commercial Footprint
Corcept Therapeutics Inc. (NASDAQ:CORT) is one of the best multibagger stocks to invest in right now.
15 Best Multibagger Stocks to Invest in Right Now
In this article, we will examine the 15 Best Multibagger Stocks to Invest in Right Now.
Canaccord Genuity Maintains a Buy on Corcept Therapeutics (CORT), Retains a $137 PT
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the most promising future stocks according to Wall Street analysts.
12 Most Promising Future Stocks According to Wall Street Analysts
In this article, we will look at the 12 Most Promising Future Stocks According to Wall Street Analysts.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q2 2025 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q2 2025 Earnings Call Transcript August 1, 2025 Operator: Thank you for standing by, and welcome to the Corcept Therapeutics Second...
H.C. Wainwright Remains Bullish on Corcept Therapeutics Incorporated (CORT)
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the most profitable biotech stocks to invest in now. On July 14, H.C.
Corcept Therapeutics Advances Pipeline Fueling Growth With Controlled Risk
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the 11 Best Long Term Low Risk Stocks to Invest in.
10 Most Profitable Biotech Stocks to Invest in Now
In this article, we will look at the 10 Most Profitable Biotech Stocks to Invest in Now.
Corcept (CORT) Advances Ovarian Cancer Therapy with FDA Filing for Relacorilant
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the growth stocks that could double by 2027.
11 Best Long Term Low Risk Stocks to Invest in
In this article, we will be looking at 11 best long term low risk stocks to buy.
Hedge Fund Resource Center
